Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

Mean absolute change results of all clinical outcomes measured in diabetes related dyslipidemia. by Manik Chhabra (10822587)

Subjects:

Participant characteristics (Mean ± SD) for each age group. by Markéta Rygelová (15453112)

Subjects:

Intrathecal injection of IGF2 siRNA decreases IGF2 mRNA expression in the spinal cord. by Wei-Hung Chan (11785304)

The geometric mean concentrations of anti-pneumococcal IgG antibodies (μg/ mL, 95% confidence intervals of the geometric mean). by Gabrielle N. Gaultier (5634923)

Subjects:

Scientists’ likelihood of using terminology sorted by overall decreasing likelihood ranking. by Jackie M. Getson (13190175)

Mean values (± standard deviation) of hormonal parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of electrolyte concentrations before and after CWI. by Aneta Teległów (9570190)

Subjects:

Related inflammation evaluation indexes before and after operation (mean±standard deviation). by Na Wang (193263)

Subjects:

Baseline data of each group (mean±standard deviation)/n (%)/(M(IQR)). by Na Wang (193263)

Subjects:

Temporal change and intergroup comparison of vessel area mean blur rate following eye drop administration. by Nana Takahashi (9999164)

Subjects:

Temporal change and intergroup comparison of tissue area mean blur rate following eye drop administration. by Nana Takahashi (9999164)

Subjects:

Temporal change in IgE. by Hiromi Yamaguchi (2396248)

Subjects:

Temporal changes in IgE. by Hiromi Yamaguchi (2396248)

Subjects:

Temporal changes in IgG. by Hiromi Yamaguchi (2396248)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

The implementation of the Level III NICU at GPHC was associated with a decrease in the monthly inborn mortality rate as a percent of all live births. by Sara Singh (10774377)

Changes in circulatory variables during CPB. by Vincent Pey (21433304)